Published in J Vasc Surg on October 01, 2008
Complement activation: an emerging player in the pathogenesis of cardiovascular disease. Scientifica (Cairo) (2012) 0.80
Regarding "Altered fibrin clot structure and function in individuals with intermittent claudication". J Vasc Surg (2009) 0.77
Polyphosphate delays fibrin polymerisation and alters the mechanical properties of the fibrin network. Thromb Haemost (2016) 0.77
Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state. Lancet (2002) 2.26
Ischemic skin ulceration complicating glue embolization of type II endoleak after endovascular aneurysm repair. J Vasc Interv Radiol (2011) 2.00
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J (2004) 1.98
Identification, classification, and expression of RAGE gene splice variants. FASEB J (2007) 1.96
Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood (2002) 1.72
Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. Am J Hum Genet (2011) 1.60
Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol (2011) 1.59
Interactions between factor XIII and the alphaC region of fibrinogen. Blood (2011) 1.58
Increased fibrinogen levels among South Asians versus Whites in the United Kingdom are not explained by common polymorphisms. Am J Epidemiol (2002) 1.52
Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arterioscler Thromb Vasc Biol (2014) 1.45
Quality of life and sexual function after traumatic pelvic fracture. J Orthop Trauma (2014) 1.44
The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain. Blood (2013) 1.42
Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation. Stroke (2009) 1.41
Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol (2013) 1.30
Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. Blood (2003) 1.29
Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. Blood (2012) 1.26
Nurse led, primary care based antiretroviral treatment versus hospital care: a controlled prospective study in Swaziland. BMC Health Serv Res (2010) 1.26
Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. Hypertension (2006) 1.25
Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness. Blood (2007) 1.25
The pleiotropic role of the fibrinogen gamma' chain in hemostasis. Blood (2009) 1.25
Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin. Blood (2010) 1.23
Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function. Circulation (2003) 1.17
Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler Thromb Vasc Biol (2004) 1.17
Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood (2011) 1.15
Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation (2002) 1.13
Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur Heart J (2007) 1.12
Predictive variables for mortality after acute ischemic stroke. Stroke (2007) 1.11
Quality and readability of online patient information for abdominal aortic aneurysms. J Vasc Surg (2012) 1.10
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary. Diab Vasc Dis Res (2014) 1.10
Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet (2003) 1.10
Abdominal aortic aneurysms: an autoimmune disease? Trends Mol Med (2008) 1.07
Functional characterization of T cells in abdominal aortic aneurysms. Immunology (2005) 1.07
Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis (2009) 1.07
Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes. ACS Nano (2010) 1.06
Genetic predictors of fibrin D-dimer levels in healthy adults. Circulation (2011) 1.05
Changes in and predictors of length of stay in hospital after surgery for breast cancer between 1997/98 and 2004/05 in two regions of England: a population-based study. BMC Health Serv Res (2009) 1.05
Increased circulating insulin-like growth factor-1 in late-onset Alzheimer's disease. J Alzheimers Dis (2007) 1.04
Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study. Arterioscler Thromb Vasc Biol (2013) 1.03
A longitudinal assessment of aflatoxin M1 excretion in breast milk of selected Egyptian mothers. Food Chem Toxicol (2007) 1.03
Inflammation and thrombosis in diabetes. Thromb Haemost (2011) 1.02
Markers of inflammation in men with small abdominal aortic aneurysm. J Vasc Surg (2010) 1.01
Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis. Diabetes (2012) 1.01
A variant in LDLR is associated with abdominal aortic aneurysm. Circ Cardiovasc Genet (2013) 1.00
The molecular physiology and pathology of fibrin structure/function. Blood Rev (2005) 1.00
The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium. Diabetes (2011) 1.00
Key challenges in the development and implementation of telehealth projects. J Telemed Telecare (2010) 1.00
Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity. Blood (2007) 0.99
An endocrinologist's guide to the clock. J Clin Endocrinol Metab (2011) 0.98
Association of frontal QRS-T angle--age risk score on admission electrocardiogram with mortality in patients admitted with an acute coronary syndrome. Am J Cardiol (2011) 0.98
Cysts and swellings: a systematic review of the association between polycystic kidney disease and abdominal aortic aneurysm. Ann Vasc Surg (2012) 0.98
Does computer-aided clinical decision support improve the management of acute abdominal pain? A systematic review. Emerg Med J (2010) 0.97
Novel role of the IGF-1 receptor in endothelial function and repair: studies in endothelium-targeted IGF-1 receptor transgenic mice. Diabetes (2012) 0.97
Multiple imputation for completion of a national clinical audit dataset. Stat Med (2011) 0.96
The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes (2003) 0.96
Dietary habits and gastric cancer risk in north-west Iran. Cancer Causes Control (2011) 0.96
The Human hydroxyacylglutathione hydrolase (HAGH) gene encodes both cytosolic and mitochondrial forms of glyoxalase II. J Biol Chem (2004) 0.95
Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation. Competition for cofactor sites on thrombin determines its fate. J Biol Chem (2003) 0.95
Fibrin clot structure in patients with end-stage renal disease. Thromb Haemost (2007) 0.95
Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler Thromb Vasc Biol (2007) 0.95
Coagulation and atherothrombotic disease. Atherosclerosis (2005) 0.93
Insulin resistance: an atherothrombotic syndrome. The Leeds family study. Thromb Haemost (2003) 0.93
α-α Cross-links increase fibrin fiber elasticity and stiffness. Biophys J (2012) 0.93
Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis. Br J Haematol (2002) 0.93
Loss and spontaneous recovery of forelimb evoked potentials in both the adult rat cuneate nucleus and somatosensory cortex following contusive cervical spinal cord injury. Exp Neurol (2007) 0.93
Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents. Diab Vasc Dis Res (2006) 0.92
Influenza vaccination in paediatric nurses: cross-sectional study of coverage, refusal, and factors in acceptance. Vaccine (2008) 0.92
Role of IGF-1 in glucose regulation and cardiovascular disease. Expert Rev Cardiovasc Ther (2008) 0.92
Genetic predisposition to fracture non-union: a case control study of a preliminary single nucleotide polymorphisms analysis of the BMP pathway. BMC Musculoskelet Disord (2011) 0.91
Using routinely collected health data to investigate the association between ethnicity and breast cancer incidence and survival: what is the impact of missing data and multiple ethnicities? Ethn Health (2011) 0.91
Benefits of family mealtimes for nursing home residents: protecting mealtimes may similarly benefit elderly inpatients. BMJ (2006) 0.90
Glutathione peroxidase 1 genotype is associated with an increased risk of coronary artery disease. Coron Artery Dis (2003) 0.90
A twin study of schizoaffective-mania, schizoaffective-depression, and other psychotic syndromes. Am J Med Genet B Neuropsychiatr Genet (2011) 0.90
Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion. Blood (2010) 0.90
Testing a workplace physical activity intervention: a cluster randomized controlled trial. Int J Behav Nutr Phys Act (2011) 0.90
Identification of quantitative trait loci for fibrin clot phenotypes: the EuroCLOT study. Arterioscler Thromb Vasc Biol (2009) 0.89
Complement C3 and C-reactive protein levels in patients with stable coronary artery disease. Thromb Haemost (2005) 0.89
Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome. Eur J Cardiovasc Prev Rehabil (2007) 0.89
Association between the risk of coronary artery disease in South Asians and a deletion polymorphism in glutathione S-transferase M1. Biomarkers (2003) 0.88
Vascular insulin-like growth factor-I resistance and diet-induced obesity. Endocrinology (2009) 0.88
Homoarginine levels are regulated by L-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies. Circulation (2013) 0.87
The characterisation and functional analysis of the human glyoxalase-1 gene using methods of bioinformatics. Gene (2004) 0.87
The Stroke Outcomes Study 2 (SOS2): a prospective, analytic cohort study of depressive symptoms after stroke. BMC Cardiovasc Disord (2009) 0.87
Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers. J Clin Endocrinol Metab (2012) 0.87
The impact of long-term warfarin on the quality of life of elderly people with atrial fibrillation. Age Ageing (2006) 0.86
Genetics of fibrin clot structure: a twin study. Blood (2003) 0.86